All Stories

  1. Expert Opinion on the Efficacy and Safety of Antispasmodics with a Focus on Irritable Bowel Syndrome
  2. Epithelial Barrier Function and Altered Cell Signaling Pathways in the Esophageal Epithelium of Achalasia Patients
  3. Extraesophageal reflux: Clinical manifestations and tools for diagnosis and treatment
  4. Prokinetics‐safety and efficacy: The European Society of Neurogastroenterology and Motility/The American Neurogastroenterology and Motility Society expert review
  5. Ege Üniversitesi Tıp Fakültesi Öğrencilerinde Çölyak Hastalığı Taraması Ve Çölyak Farkındalığı Çalışması
  6. Revisiting the Role of Esophageal Mucosal Dilated Intercellular Spaces in the Diagnosis and Pathophysiology of Heartburn
  7. Computer-Based Intelligent Solutions for the Diagnosis of Gastroesophageal Reflux Disease Phenotypes and Chicago Classification 3.0
  8. Face‐to‐face interviews versus Internet surveys: Comparison of two data collection methods in the Rome foundation global epidemiology study: Implications for population‐based research
  9. Validation of the Reflux Disease Questionnaire for a Turkish Population
  10. Chicago Classification update (v4.0): Technical review of high‐resolution manometry metrics for EGJ barrier function
  11. European Society for Neurogastroenterology and Motility (ESNM) recommendations for the use of high‐resolution manometry of the esophagus
  12. Esophagogastric junction morphology and contractile integral on high‐resolution manometry in asymptomatic healthy volunteers: An international multicenter study
  13. Trimebutine Maleate Monotherapy for Functional Dyspepsia: A Multicenter, Randomized, Double-Blind Placebo Controlled Prospective Trial
  14. European Society for Neurogastroenterology and Motility (ESNM) recommendations for conducting gastrointestinal motility and function testing in the recovery phase of the COVID‐19 pandemic
  15. Population-based assessment of gastrointestinal symptoms and diseases: Cappadocia Cohort, Turkey
  16. Validation of Peptest™ in Patients with Gastro-Esophageal Reflux Disease and Laryngopharyngeal Reflux Undergoing Impedance Testing
  17. Alginates: From the ocean to gastroesophageal reflux disease treatment
  18. Reflux esophagitis, functional and non-functional
  19. How to select patients for antireflux surgery? The ICARUS guidelines (international consensus regarding preoperative examinations and clinical characteristics assessment to select adult patients for antireflux surgery)
  20. Validity and reliability of the Quality of Life in Reflux and Dyspepsia (QoLRAD) questionnaire in patients with gastroesophageal reflux disease for the Turkish population
  21. A meta-analysis on the cardiac safety profile of domperidone compared to metoclopramide
  22. Proximal Baseline Impedance Analysis Might be a Valuable Clue for Extraesophageal Reflux Diagnosis
  23. Allergic rhinitis in eosinophilic esophagitis
  24. Consensus Report on Gastroesophageal Reflux Disease in Turkey
  25. How is the gastroesophageal reflux disease prevalence, incidence, and frequency of complications (stricture/esophagitis/Barrett’s esophagus/ carcinoma) in Turkey compared to other geographical regions globally?
  26. Medical treatment of gastroesophageal reflux disease
  27. Classification of esophageal motor findings in gastro-esophageal reflux disease: Conclusions from an international consensus group
  28. Ambulatory reflux monitoring for diagnosis of gastro-esophageal reflux disease: Update of the Porto consensus and recommendations from an international consensus group
  29. Biomarkers of Reflux Disease
  30. The Role of Microaspiration in the Pathogenesis of Gastroesophageal Reflux-related Chronic Cough
  31. Prevalence of gastroesophageal reflux disease in a country with a high occurrence ofHelicobacter pylori
  32. The diagnostic value of 24-hour ambulatory intraesophageal pH-impedance in patients with laryngopharyngeal reflux symptoms comparable with typical symptoms
  33. The sensory system of the esophagus--what do we know?
  34. Prevalence of Psychiatric Comorbidity in Symptomatic Gastroesophageal Reflux Subgroups
  35. Esophageal Epithelial Resistance and Lower Esophageal Sphincter Muscle Contraction Increase in a Chronic Diabetic Rabbit Model
  36. In vitro fertilization-induced pregnancies predispose to gastroesophageal reflux disease
  37. The effect of antireflux surgery on laryngeal symptoms, findings and voice parameters
  38. BOB CAT: a Large-Scale Review and Delphi Consensus for Management of Barrett’s Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia
  39. The last innovation in achalasia treatment; per-oral endoscopic myotomy
  40. Investigation of intra-esophageal air kinetics and esophageal sphincters in patients with total laryngectomy during esophageal speech
  41. Prevalence of gastroesophageal reflux disease in Moscow
  42. Effects of a kefir supplement on symptoms, colonic transit, and bowel satisfaction score in patients with chronic constipation: A pilot study
  43. The Turkish version of the Rome III criteria for IBS is valid and reliable
  44. Sexual activity does not predispose to reflux episodes in patients with gastroesophageal reflux disease
  45. Obstructive sleep apnea syndrome and gastroesophageal reflux disease: the importance of obesity and gender
  46. Predictive value of esophageal motility test in the proficiency of esophageal speech
  47. Tissue resistance in the normal and diseased esophagus
  48. The influence of the speed of food intake on multichannel impedance in patients with gastro-oesophageal reflux disease
  49. Impact of Laryngeal Findings on Acoustic Parameters of Patients with Laryngopharyngeal Reflux
  50. Relationship between history, laryngoscopy and esophagogastroduodenoscopy for diagnosis of laryngopharyngeal reflux in patients with typical GERD
  51. Effects of ethanol and extract of cigarette smoke on the rabbit buccal mucosa
  52. Prevalence of gastroesophageal reflux disease in patients with asthma and chronic obstructive pulmonary disease
  53. Validity and Reliability of a Turkish Version of the Fecal Incontinence Quality of Life Scale
  54. Esophageal intramural pseudodiverticulosis associated with achalasia: an unusual endoscopic appearance
  55. The additive effect of ethanol and extract of cigarette smoke on rabbit esophagus epithelium
  56. Esomeprazole in acute and maintenance treatment of reflux oesophagitis: a multicentre prospective study
  57. Prevalence patterns of gastric cancers in Turkey: Model of a developing country with high occurrence of Helicobacter pylori
  58. Association of Heartburn During Pregnancy With the Risk of Gastroesophageal Reflux Disease
  59. The effect of laparoscopic Nissen fundoplication on laryngeal findings and voice quality
  60. Use of case-based exams as an instructional teaching tool to teach clinical reasoning
  61. Efficacy and safety of Saccharomyces boulardii in prevention of antibiotic-associated diarrhoea due to Helicobacterpylori eradication
  62. Eosinophil infiltration of the oesophageal mucosa in patients with pollen allergy during the season
  63. Swallow-Induced Syncope in a Patient with Achalasia
  64. Gastroesophageal Reflux Disease in a Low-Income Region in Turkey
  65. Preswallowing Dystonia
  66. Psychometric and methodological characteristics of a culturally adjusted gastroesophageal reflux disease questionnaire
  67. Manometric assessment of esophageal motility in patients with primary Sjögren’s syndrome
  68. Eosinophilic bronchitis as a cause of chronic cough
  69. The comparison of an empiric proton pump inhibitor trial vs 24-hour double-probe Ph monitoring in laryngopharyngeal reflux
  70. Is administration n-3 fatty acids by enema mucosal protective against trinitrobenzene-induced colitis in rats?